Aurinia Pharmaceuticals Inc. has 5 Schedule 13D or 13G filings on record since 2025-08-13. 1 holder's latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Tang Capital Management, LLC | 10% | 13,044,106 | SCHEDULE 13D/A, 2026-06-04 | 2026-06-02 |
| ILJIN SNT Co., Ltd. | 4.4% | 4,987,629 | SCHEDULE 13D/A, 2026-08-26 | 2026-08-20 |
Purpose of Transaction (Item 4)
Tang Capital Management, LLC
Item 4 of the Original Schedule 13D is hereby amended and restated by replacing the text thereof in its entirety with the following: The Reporting Persons' acquisition was made for investment purposes. In accordance with applicable securities laws, the Reporting Persons may, from time to time and at any time, acquire additional shares and/or other equity, debt or other securities or instruments (collectively, "Securities") of the Issuer in the open market or otherwise, and reserves the right to dispose of any or all of its Securities in the open market or otherwise at any time and from time to time, and to engage in similar transactions with respect to the Securities, the whole depending on market conditions, the business and prospects of the Issuer and other relevant factors.Item 4 of the SCHEDULE 13D/A filed 2026-06-04
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | ILJIN SNT Co., Ltd. | 5% | SCHEDULE 13D/A |
| 2026-03-03 | Tang Capital Management, LLC | 9.2% | SCHEDULE 13D/A |
| 2026-03-25 | Tang Capital Management, LLC | 9.2% | SCHEDULE 13D/A |
| 2026-06-04 | Tang Capital Management, LLC | 10% | SCHEDULE 13D/A |
| 2026-08-26 | ILJIN SNT Co., Ltd. | 4.4% | SCHEDULE 13D/A |
Tools for this story
Each opens in a new tab, filled in for Aurinia Pharmaceuticals Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.